Abstract
Background: Prophylactic central compartment lymph node dissection (PCLND) or watchful waiting are two currently used strategies in papillary thyroid cancer (PTC) treatment. Choosing between these two strategies for an individual patient is difficult due to low specificity of preoperative imaging modalities for central compartment nodal metastases. PCLND reduces recurrence rates but exposes pN0 patients to undesirable morbidity. Reoperation for local recurrence after watchful waiting is challenging and causes even higher morbidity rates. Since MET is overexpressed in PTC compared to normal thyroid tissue, we tested the feasibility of intraoperative molecular fluorescence guided imaging (MFGI) of EMI-137 (targeting MET) to improve detection of PTC nodal metastasis. MFGI may improve patient selection for CLND, ultimately reducing recurrence rates and morbidity in PTC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
